Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

17
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
17
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

27
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

25
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

31
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
31
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

29
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targetable alterations and personalized treatment in ameloblastoma: results from a prospective observational precision oncology study.

NPJ precision oncology·2026
Same author

iFLinkC-EZ: A scalable and automatable method for the assembly of complex fusion proteins and multi-gene expression constructs based on the iFLinkC framework.

Synthetic and systems biotechnology·2026
Same author

Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise?

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

A deep learning model for histopathological diagnosis of actinic keratosis: a diagnostic case control accuracy study.

Italian journal of dermatology and venereology·2026
Same author

Benefits and challenges of asynchronous telemedicine in obtaining a second opinion: a qualitative interview study.

BMJ open·2025
Same author

Infectious Endocarditis Is Associated with Dental Treatment or Poor Dental Status-Results from the Brandenburg Endocarditis Registry (B.E.R.).

Journal of clinical medicine·2025

Related Experiment Video

Updated: Aug 28, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K

Do Not Withhold Mitral Surgery from Patients with Poor Left Ventricular Function.

Roya Ostovar1, Max Schmidt1, Filip Schroeter1

  • 1Department of Cardiovascular Surgery, Heart Center Brandenburg, University Hospital Brandenburg, Faculty of Health Sciences Brandenburg, Medical School Theodor Fontane, 16321 Bernau, Germany.

Medicina (Kaunas, Lithuania)
|September 23, 2022
PubMed
Summary
This summary is machine-generated.

Poor left ventricular ejection fraction (LVEF) does not significantly impact surgical outcomes for mitral valve procedures. This suggests surgery is a viable option, even for high-risk patients, rather than solely relying on less effective interventions.

Keywords:
left ventricular ejection fractionmitral valve surgerymortality

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K

Related Experiment Videos

Last Updated: Aug 28, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Increasing reluctance exists for surgical mitral valve intervention in high-risk patients with poor left ventricular function.
  • Interventional options like MitraClip offer limited improvement for these complex cases.

Purpose of the Study:

  • To determine if preoperative left ventricular ejection fraction (LVEF) influences postoperative mortality after mitral valve surgery.

Main Methods:

  • Analysis of 903 patients undergoing mitral valve repair/replacement (2009-2021).
  • Comparison between patients with LVEF ≤ 30% and LVEF > 30%.
  • Propensity score matching (1:3) for statistical analysis.

Main Results:

  • No significant difference in in-hospital mortality between LVEF groups, pre- and post-matching.
  • Patients with LVEF ≤ 30% had higher NT-proBNP, larger cardiac chamber diameters, and lower TAPSE/PAP.
  • These patients also presented with more dilated cardiomyopathy and chronic kidney disease.

Conclusions:

  • Poor preoperative LVEF alone is not a significant predictor of postoperative outcome or long-term mortality.
  • Mitral valve surgery remains a valid option for patients with poor LVEF, not a contraindication.
  • Prognosis in these patients is multifactorial, warranting comprehensive assessment beyond LVEF.